Smooth Drug Development August 2023 News Release

We are working on the following new projects:

• We were awarded with medical writing activities for bioequivalence trials with Triptorelin.
• Smooth received a project for a phase II-III trial in flu.
• We were awarded with a contract for a scientifical article for an international pharma company.

We are happy to reach the following milestones in our projects:

• We prepared CTA submission documents for the Edoxaban trial.
• 3 BE trials with Dolutegravir and Empagliflozin 10 mg and 25 mg were launched.
• 900 subjects are enrolled in the observational program of multivitamins in pregnant and childbearing women.